BMC Medical Co., Ltd. (SHE:301367)
China · Delayed Price · Currency is CNY 46.64
+0.08 (0.17%)
At close: Sep 30, 2026
BMC Medical Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 220.89 | 225.66 | 155.38 | 297.34 | 380.3 | 145.68 |
Depreciation & Amortization | 21.51 | 21.42 | 21.93 | 19.4 | 8.74 | 8.81 |
Other Amortization | 7.12 | 6.07 | 4.91 | 3.93 | 2.29 | 1.78 |
Loss (Gain) From Sale of Assets | -0.26 | -0.26 | -0.19 | -0.48 | -0.02 | - |
Asset Writedown & Restructuring Costs | 0.86 | 0.83 | 3.06 | 0.02 | 3.77 | 0.25 |
Loss (Gain) From Sale of Investments | -42.46 | -50.48 | -60.36 | -57.17 | -14.82 | -8.46 |
Provision & Write-off of Bad Debts | 2.64 | 2.4 | 2.75 | 2.8 | - | - |
Other Operating Activities | 49.59 | 36.37 | 13.96 | 13.97 | -10.78 | 3.87 |
Change in Accounts Receivable | -124.42 | -135.35 | -67.95 | -21.97 | -63.53 | -19.68 |
Change in Inventory | -102.03 | -23 | 2.86 | 75.06 | -86.08 | -69.78 |
Change in Accounts Payable | 128.7 | 42.03 | 80.68 | -183.63 | 158.51 | 42.54 |
Change in Other Net Operating Assets | 21.37 | 13.55 | - | - | - | - |
Operating Cash Flow | 173.63 | 130.16 | 154.08 | 151.11 | 375.21 | 104.4 |
Operating Cash Flow Growth | 36.97% | -15.53% | 1.97% | -59.73% | 259.39% | -60.96% |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Capital Expenditures | -40.32 | -32.22 | -15.93 | -24.12 | -23.75 | -10.03 |
Sale of Property, Plant & Equipment | 0.15 | 0.15 | 0.48 | 0.16 | 0.08 | 0 |
Cash Acquisitions | - | - | - | - | 5.86 | - |
Investment in Securities | 292.77 | 763.09 | -638.12 | 268.44 | -1,859 | -164.85 |
Other Investing Activities | 35.36 | 88.2 | 52.46 | 57.43 | 1 | - |
Investing Cash Flow | 287.95 | 819.22 | -601.1 | 301.9 | -1,876 | -174.87 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Short-Term Debt Issued | - | 447.31 | 384.49 | - | - | - |
Total Debt Issued | 224.98 | 447.31 | 384.49 | - | - | - |
Short-Term Debt Repaid | - | -706.47 | - | - | - | - |
Long-Term Debt Repaid | - | -12.39 | -11.44 | -9.76 | -3.12 | -1.38 |
Lease Payments | -11.8 | -12.39 | -11.44 | -9.76 | -3.12 | -1.38 |
Total Debt Repaid | -404.53 | -718.86 | -11.44 | -9.76 | -3.12 | -1.38 |
Net Debt Issued (Repaid) | -179.56 | -271.55 | 373.05 | -9.76 | -3.12 | -1.38 |
Issuance of Common Stock | 12.95 | - | - | - | 1,764 | - |
Repurchase of Common Stock | -63.07 | -2.02 | -42.26 | - | - | - |
Common Dividends Paid | -61.71 | -41.94 | -65.79 | -128 | - | -28.8 |
Other Financing Activities | -10.24 | -27.07 | -25.07 | -2 | -25.86 | - |
Financing Cash Flow | -301.62 | -342.58 | 239.93 | -139.76 | 1,735 | -30.18 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Foreign Exchange Rate Adjustments | -27.02 | -3.2 | 4.36 | -0.41 | 7.59 | -3.67 |
Net Cash Flow | 132.95 | 603.6 | -202.73 | 312.84 | 241.89 | -104.32 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Free Cash Flow | 133.31 | 97.94 | 138.16 | 126.98 | 351.46 | 94.38 |
Free Cash Flow Growth | 19.36% | -29.11% | 8.80% | -63.87% | 272.41% | -62.55% |
Free Cash Flow Margin | 9.67% | 8.45% | 16.38% | 11.31% | 24.83% | 14.24% |
Free Cash Flow Per Share | 1.07 | 0.79 | 1.10 | 1.01 | 3.54 | 1.00 |
Levered Free Cash Flow | 95.07 | 69.93 | 94.07 | 44.8 | 242.34 | 49.67 |
Unlevered Free Cash Flow | 96.54 | 73.03 | 95.85 | 45.65 | 242.63 | 49.8 |
Free Cash Flow After Leases | 121.5 | 85.56 | 126.72 | 117.22 | 348.34 | 93 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash Income Tax Paid | 7.79 | 62.03 | 3.49 | -5.79 | -77.83 | 2.23 |
Change in Working Capital | -86.25 | -111.84 | 12.66 | -128.7 | 5.73 | -47.52 |